Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on November 1, 2007

Stroke. 2007
Published online before print November 1, 2007, doi: 10.1161/STROKEAHA.107.499319
A more recent version of this article appeared on December 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/12/3237    most recent
STROKEAHA.107.499319v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lelong, D. C.
Right arrow Articles by Abitbol, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lelong, D. C.
Right arrow Articles by Abitbol, M.
Related Collections
Right arrow Electrophysiology
Right arrow Animal models of human disease
Right arrow Other diagnostic testing
Right arrow Acute Cerebral Infarction
Right arrow Acute Stroke Syndromes
Right arrow Brain Circulation and Metabolism
Right arrow Angiography

Submitted on July 13, 2007
Accepted on August 7, 2007

Novel Mouse Model of Monocular Amaurosis Fugax

Dominique Claude Lelong MD; Ivan Bieche PhD; Elodie Perez MSc; Karine Bigot PhD; Julia Leemput MSc; Ingrid Laurendeau MSc; Michel Vidaud PhD; Jean-Philippe Jais MD, PhD; Maurice Menasche PhD; and Marc Abitbol MD, PhD*

From the Centre de Recherche Thérapeutique en Ophtalmologie-CERTO (D.C.L., K.B., E.P., J.L., M.M., M.A.), Faculté de Médecine Paris Descartes; Laboratoire de Génétique Moléculaire (I.B., I.L., M.V.), INSERM U745, Faculté des Sciences Pharmaceutiques et Biologiques; and Service de biostatistiques et d'informatique médicale (J.-P.J.), Faculté de Médecine Paris Descartes, Paris, France.

* To whom correspondence should be addressed. E-mail: abitbol{at}necker.fr.

Background and Purpose—Retinal ischemia is a major cause of visual impairment and is associated with a high risk of subsequent ischemic stroke. The retina and its projections are easily accessible for experimental procedures and functional evaluation. We created and characterized a mouse model of global and transient retinal ischemia and provide a comprehensive chronologic profile of some genes that display altered expression during ischemia.

Methods—Ischemia and reperfusion were assessed by observing flat-mounted retinas after systemic fluorescein injection. The temporal pattern of gene expression modulation was evaluated by quantitative reverse transcription–polymerase chain reaction from the occurrence of unilateral 30-minute pterygopalatine artery occlusion until 4 weeks after reperfusion. Electroretinograms evaluated functional sequelae 4 weeks after the ischemic episode and were correlated with histologic lesions.

Results—This model is the first to reproduce the features of transient monocular amaurosis fugax resulting from ophthalmic artery occlusion. The histologic structure was roughly conserved, but functional lesions affected ganglion cells, inner nuclear layer cells, and photoreceptor cells. We observed an early and strong upregulation of c-fos, c-jun, Cox-2, Hsp70, and Gadd34 gene expression and a late decrease in Hsp70 transcript levels.

Conclusions—A murine model of transient retinal ischemia was successfully developed that exhibited the characteristic upregulation of immediate-early genes and persistent functional deficits. The model should prove useful for investigating mechanisms of injury in genetically altered mice and for testing novel neuroprotective drugs.


Key words: animal models • Gadd34 • heat-shock proteins • retinal ischemia